Home » Guidance Clarifies Certification Requirements for Clinical Trial Sponsors
Guidance Clarifies Certification Requirements for Clinical Trial Sponsors
February 17, 2009
Drugmakers submitting investigational new drug (IND) applications with new clinical trial protocols are advised to certify to the U.S. Food and Drug Administration (FDA) that they have met all requirements of the clinical trial database registry law, according to a final guidance.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor